Schedule 13D ownership disclosure

JASPER THERAPEUTICS INC

Security class unavailable · CUSIP: 471871103

Event date: 2021-09-24

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,628,558
Percent of class
15.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000905718-21-001266
Form type
SC 13D
Filer
Abingworth LLP
CIK
CIK 1397144
Filed
Oct 04, 2021
Reporting period
Sep 24, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub